• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CIBA VISION GMBH PRECISION1 FOR ASTIGMATISM; LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CIBA VISION GMBH PRECISION1 FOR ASTIGMATISM; LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Catalog Number 000000000010170438
Device Problem Material Split, Cut or Torn (4008)
Patient Problems Corneal Ulcer (1796); Eye Pain (4467)
Event Date 09/08/2021
Event Type  Injury  
Manufacturer Narrative
The complaint sample has not returned for evaluation; the lot number is n4023837.Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
An optician reported that she experienced "intense" pain in the left eye (os) with a pair of trial contact lenses, as well as experiencing a contact lens tearing during wear.She consulted a physician and was diagnosed with a corneal ulcer in the os.At this time of this report, the current status of the eye is not known; additional information has been requested but not yet received.
 
Event Description
Follow-up information received on 27sep2021 states that the reported event of corneal ulcer occurred after two days of wearing the complaint device.
 
Manufacturer Narrative
H.3., h.6.: the complaint product has not yet been received at the verification center for evaluation.The device history record and sterilization record for this lot have been reviewed and found to be in compliance.There was no nonconformity or deviations during the manufacturing process which related to the nature of the complaint.The root cause could not be determined.The manufacturer internal reference number is: (b)(4).
 
Event Description
Follow-up information received on 09oct2021 states that consumer experienced severe rapid onset acute pain and excessive tearing after two days of wear.The consumer was seen by an ophthalmologist and was diagnosed with a corneal ulcer in the left eye (peripheral location, 2mm or less in size).Consumer was prescribed with hexamidine, tobramycin and ciprofloxacin drops.The consumer had also temporarily stopped to wear the contact lenses.At the time of this report symptoms were resolved and consumer plans to resume wearing the contact lenses.
 
Manufacturer Narrative
A.2, b.5: additional information b.2: based on the additional information received, this event no longer meets reportability requirements, and the previous outcome reported of "other serious" no longer applies.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISION1 FOR ASTIGMATISM
Type of Device
LENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
CIBA VISION GMBH
postfach, industriering 1
grosswallstadt D-638 68
GM  D-63868
MDR Report Key12518758
MDR Text Key272889487
Report Number9610813-2021-00017
Device Sequence Number1
Product Code LPL
Combination Product (y/n)N
PMA/PMN Number
K182902
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,health profe
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 10/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number000000000010170438
Device Lot NumberN4023837
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/12/2021
Initial Date Manufacturer Received 09/08/2021
Initial Date FDA Received09/23/2021
Supplement Dates Manufacturer Received09/23/2021
10/09/2021
Supplement Dates FDA Received10/11/2021
10/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age33 YR
-
-